Trading Statement ADVANCED HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2013/059246/06) (“the Company” or “Advanced Health”) ISIN Code: ZAE000189049 JSE Code: AVL TRADING STATEMENT In terms of paragraph 3.4(b)(i) of the Listings Requirements of the JSE Limited, listed companies are required to publish a trading statement as soon as they become reasonably certain that the financial results for the next period to be reported on will differ by more than 20% from those of the previous corresponding period. The directors of Advanced Health hereby advise shareholders that, in respect of the reviewed consolidated results for the year ended 30 June 2021, the Company expects a loss per share ranging between 4.17 cents and 6.25 cents, compared to a loss per share of 51.08 cents for the comparative year ended 30 June 2020. This equates to an improvement of between 88% and 92%. The headline loss per share for the year ended 30 June 2021 is expected to range between 1.68 cents and 2.52 cents, compared to a headline loss per share of 49.42 cents for the comparative year ended 30 June 2020. This equates to an improvement of between 95% to 97%. The information in this trading statement has not been reviewed and reported on by the Company’s auditors. Pretoria. 25 August 2021 Designated Advisor Grindrod Bank Limited Date: 25-08-2021 07:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.